Pierre Goldschmidt
Source: Getty
Has Fereydoun Abbasi Been Called to Order?
The latest statements made by the head of Iran's Atomic Energy Organization regarding the country's willingness to cooperate with the International Atomic Energy Agency do not bode well for the success of the recent Russian initiative to reinvigorate multilateral nuclear talks.
At the end of August it was reported1 that Fereydoun Abbasi, the head of Iran’s Atomic Energy Organisation, had suggested that “Iran is ready for increased cooperation with the IAEA on the condition the U.N. watchdog limit the number of points it wants clarified,” adding “As long as we don’t receive these questions in an official manner, we cannot respond.”
About the Author
Former Nonresident Senior Associate, Nuclear Policy Program
Goldschmidt was a nonresident senior associate at the Carnegie Endowment.
- A Realistic Approach Toward a Middle East Free of WMDArticle
- Serious Deficiencies Exposed by Latest IAEA Safeguards Implementation ReportArticle
Pierre Goldschmidt
Recent Work
Carnegie India does not take institutional positions on public policy issues; the views represented herein are those of the author(s) and do not necessarily reflect the views of Carnegie, its staff, or its trustees.
More Work from Carnegie India
- Risk and Retaliation: Israel, Iran, and the Evolving Situation in West AsiaArticle
An Israeli response to Iran’s October 1 attack is imminent. The key question is of its intensity and potential fallout, both within Iran, in terms of nuclear security policy changes, and across the broader region. The coming days are likely to reshape West Asia irreversibly.
Gaddam Dharmendra
- How WHO’s “One Health” Program Can Help India Tackle MonkeypoxCommentary
With monkeypox being declared a global health emergency, the WHO approach is an innovative and effective way to curb outbreaks of zoonotic diseases.
Shruti Sharma
- Lessons from the Coronavirus Pandemic: Leveraging Biotechnology to Tackle Infectious Diseases in IndiaPaper
In India, biotechnology has played an important role in helping stakeholders in academia, industry, and government develop new pandemic-related technology, from test kits to respiratory devices. But these biotechnology advancements can go further to strengthen India’s public health capacity.
Shruti Sharma
- Combating Vaccine Hesitancy in IndiaCommentary
Unless the government can up its communications game, anti-vax movements could prolong India’s pandemic effects.
Shruti Sharma
- How Should Countries Study Viruses Safely?Commentary
The uncertain origin of the coronavirus has focused attention on gain-of-function research—studying viruses to learn how they spread. How can countries work together to ensure stringent safety standards?
Shruti Sharma